4.6 Review

Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions

Mark Edmondson-Jones et al.

Summary: The study found that the incidence of OM in children under 2 years old decreased after the introduction of PHiD-CV and PCV13, with PHiD-CV showing a significant reduction in OM incidence in adjusted models.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Biotechnology & Applied Microbiology

Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia

Gabriel Carrasquilla et al.

Summary: After the introduction of pneumococcal conjugate vaccines (PCVs) in Colombia, overall reductions in disease outcomes were observed in most cities and nationwide. However, in some cities, there was an increase in the incidence of otitis media despite the decrease in pneumonia incidence.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Immunology

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe

Gail L. Rodgers et al.

Summary: Pneumococcal conjugate vaccine has successfully reduced the burden of disease and provided herd protection for those who cannot be vaccinated. While widely rolled out in poor countries, there are still many unvaccinated children in middle income countries. Solutions being considered include reducing doses and supporting more affordable vaccine sources.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Immunology

National decision-making for the introduction of new vaccines: A systematic review, 2010-2020

Morgane Donadel et al.

Summary: This study conducted a literature review to document the processes and frameworks for national decision-making on new vaccine introductions and explored key features that have evolved since 2010. The results indicated that policymakers increasingly value interventions based on economic evaluations, and evidence-informed recommendations play a crucial role in vaccine adoption decision-making. The findings could guide discussions on evidence-informed immunization decision-making among stakeholders.

VACCINE (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Immunology

Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

Megan E. Peck et al.

Summary: The study found that countries participating in or conducting surveillance for invasive pneumococcal disease or rotavirus disease were more likely to introduce PCV or rotavirus vaccine. However, there is currently insufficient evidence to demonstrate whether countries with higher rotavirus positivity are more likely to introduce the vaccine.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States

Shelly Senders et al.

Summary: The study demonstrated that administration of PCV20 in healthy US infants was well tolerated, with a safety profile similar to PCV13, and induced robust serotype-specific immune responses. These findings support continued development of PCV20 in the pediatric population.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Article Public, Environmental & Occupational Health

Burden of respiratory infections and otitis media in the Inuit population of Nunavik, Quebec, Canada

Philippe De Wals et al.

INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH (2020)

Editorial Material Pediatrics

Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe

Corinne Levy et al.

JOURNAL OF PEDIATRICS (2019)

Article Medicine, Research & Experimental

Pediatric acute mastoiditis in the era of pneumococcal vaccination

Kareem O. Tawfik et al.

LARYNGOSCOPE (2018)

Article Otorhinolaryngology

Influence of pneumococcal conjugate vaccines on acute otitis media in Japan

Atsushi Sasaki et al.

AURIS NASUS LARYNX (2018)

Article Immunology

Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination A National Observational Study

Marie Gisselsson-Solen

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)

Article Immunology

Decreased Incidence of Respiratory Infections in Children After Vaccination with Ten-valent Pneumococcal Vaccine

Samuel Sigurdsson et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)

Article Pediatrics

Pneumococcal vaccination reduced the risk of acute otitis media: Cohort study

Junko Hasegawa et al.

PEDIATRICS INTERNATIONAL (2015)

Article Pediatrics

The Diagnosis and Management of Acute Otitis Media

Allan S. Lieberthal et al.

PEDIATRICS (2013)

Review Immunology

Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review

Sylvia Taylor et al.

CLINICAL INFECTIOUS DISEASES (2012)

Review Immunology

Seven-valent pneumococcal conjugate vaccines for developing countries

Stephen Obaro

EXPERT REVIEW OF VACCINES (2009)

Article Medicine, General & Internal

Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings

Carlos G. Grijalva et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Pediatrics

The burden of acute otitis media on the patient and the family

D Greenberg et al.

EUROPEAN JOURNAL OF PEDIATRICS (2003)